Evaluating the effectiveness and safety of Spartina® (Tirzepatide manufactured by CinnaGen Co.) in patients with obesity and type 1 diabetes

Authors
Category Primary study
Registry of TrialsIranian Registry of Clinical Trials
Year 2026
This article has no abstract
Epistemonikos ID: 95ef16c9583b29a136eb3d2043a587b3cd5a1fb8
First added on: Oct 30, 2026